A multicenter study of niraparib as maintenance therapy in BRCA wild-type, newly diagnosed advanced ovarian cancer (Polo trial)

被引：0
|
作者：
Kim, Se Ik [1 ]
Choi, Chel Hun [2 ]
Kim, Ji Hyun [3 ,4 ]
Lee, Yong Jae [5 ]
Park, Jeong-Yeol [6 ]
Suh, Dong Hoon [7 ]
Kim, Yong Beom [7 ]
Lee, Jung-Yun [5 ]
Lim, Myong Cheol [3 ,4 ]
Kim, Byoung Gie [2 ]
Kim, Jae-Weon [1 ]
机构：
[1] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea
[2] Sungkyunkwan Univ, Dept Obstet & Gynecol, Sch Med, Samsung Med Ctr, Seoul, South Korea
[3] Natl Canc Ctr, Ctr Gynecol Canc, Goyang Si, South Korea
[4] Ctr Clin Trial, Goyang Si, South Korea
[5] Yonsei Univ, Coll Med, Inst Womens Life Med Sci, Dept Obstet & Gynecol, Seoul, South Korea
[6] Asan Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea
[7] Seoul Natl Univ, Dept Obstet & Gynecol, Bundang Hosp, Seongnam Si, South Korea
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2023年 / 33卷 / SUPPL_4期
关键词：
D O I：
10.1136/ijgc-2023-IGCS.476
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TP016
引用
收藏
页码：A252 / A252
页数：1
相关论文
共 50 条
  • [31] Flames: randomized phase 3 trial of maintenance senaparib in patients with newly diagnosed advanced ovarian cancer
    Wu, Xiaohua
    Liu, Jihong
    Wang, Xiaobin
    Wang, Jing
    Wang, Li
    Zhu, Jianqing
    Kong, Beihua
    Fei, Junwei
    Tang, Ying
    Xia, Bairong
    Liang, Zhiqing
    Wang, Ke
    Lin, Zhongqiu
    Huang, Yi
    Zheng, Hong
    Lin, An
    Jiang, Kui
    Wang, Wei
    Wang, Xin
    Lou, Ge
    Pan, Hongming
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A10 - A11
  • [32] MEDx HRDetectCDx predicts the response of newly diagnosed advanced ovarian cancer patients in china to first-line maintenance treatment with niraparib
    Zuo, Jing
    Wang, Ke
    Cui, Zhumei
    Zhang, Hui
    Li, Qingshui
    Wang, Shuhe
    Sun, Lixin
    Zhang, Jun
    Zheng, Min
    Zhao, Hongqin
    Chen, Xiaoxiang
    Cheng, Xiaodong
    Hong, Li
    Gao, Yang
    Song, Wenhui
    Wang, Yu
    Zhao, Jiaxing
    Jiang, Zeyu
    Zhang, Yafei
    Wu, Lingying
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A316 - A316
  • [33] Olaparib maintenance therapy in patients with newly diagnosed advanced ovarian cancer and a BRCA1 and/or BRCA2 mutation: SOLO1 China cohort
    Wu, Lingying
    Zhu, Jianqing
    Yin, Rutie
    Wu, Xiaohua
    Lou, Ge
    Wang, Jing
    Gao, Yunong
    Kong, Beihua
    Lu, Xin
    Zhou, Qi
    Wang, Yueling
    Chen, Youguo
    Lu, Weiguo
    Li, Wei
    Cheng, Ying
    Liu, Jihong
    Ma, Xin
    Zhang, Jing
    GYNECOLOGIC ONCOLOGY, 2021, 160 (01) : 175 - 181
  • [34] NIRVANA-1: maintenance therapy with niraparib versus niraparib-bevacizumab in patients with advanced ovarian cancer
    Sghaier, Syrine
    Corbaux, Pauline
    Ray-Coquard, Isabelle
    Lim, Myong Cheol
    Hasegawa, Kosei
    Van Nieuwenhuysen, Els
    Gonzalez, Antonio
    Raspagliesi, Francesco
    Freyer, Gilles
    FUTURE ONCOLOGY, 2023, 19 (25) : 1715 - 1727
  • [35] Efficacy and safety of niraparib maintenance therapy in patients with newly diagnosed advanced ovarian cancer who had measurable residual disease: A post-hoc subgroup analysis of the PRIME study
    Kong, Beihua
    Wu, Lingying
    Zhu, Jianqing
    Yin, Rutie
    Wang, Jing
    Pan, Lingya
    Zheng, Hong
    Liu, Jihong
    Wu, Xiaohua
    Wang, Li
    Huang, Yi
    Wang, Ke
    Zou, Dongling
    Zhao, Hongqin
    Wang, Chunyan
    Lu, Weiguo
    Lin, An
    Zhen, Xiaoa
    Hang, Wenzhao
    Hou, Jianmei
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [36] Maintenance therapy for newly diagnosed epithelial ovarian cancer- a review
    Nag, Shona
    Aggarwal, Shyam
    Rauthan, Amit
    Warrier, Narayanankutty
    JOURNAL OF OVARIAN RESEARCH, 2022, 15 (01)
  • [37] Efficacy of Maintenance Olaparib for Patients With Newly Diagnosed Advanced Ovarian Cancer With a BRCA Mutation: Subgroup Analysis Findings From the SOLO1 Trial
    DiSilvestro, Paul
    Colombo, Nicoletta
    Scambia, Giovanni
    Kim, Byoung-Gie
    Oaknin, Ana
    Friedlander, Michael
    Lisyanskaya, Alla
    Floquet, Anne
    Leary, Alexandra
    Sonke, Gabe S.
    Gourley, Charlie
    Banerjee, Susana
    Oza, Amit
    Gonzalez-Martin, Antonio
    Aghajanian, Carol A.
    Bradley, William H.
    Mathews, Cara A.
    Liu, Joyce
    Lowe, Elizabeth S.
    Bloomfield, Ralph
    Moore, Kathleen N.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (30) : 3528 - +
  • [38] Niraparib Population Pharmacokinetics and Exposure-Response Relationships in Patients With Newly Diagnosed Advanced Ovarian Cancer
    Monk, Bradley J.
    Romero, Ignacio
    Graybill, Whitney
    Churruca, Cristina
    O'Malley, David M.
    Knudsen, Anja or
    Yap, Oi Wah Stephanie
    Baurain, Jean-Francois
    Rose, Peter G.
    Denys, Hannelore
    Ghamande, Sharad
    Pisano, Carmela
    Fabbro, Michel
    Braicu, Elena Ioana
    Calvert, Paula M.
    Amit, Amnon
    Prendergast, Emily
    Taylor, Adekemi
    Kheibarshekan, Leila
    Zhang, Zhi-Yi
    Zajic, Stefan
    Jewell, Roxanne C.
    Gupta, Divya
    Gonzalez-Martin, Antonio
    CLINICAL THERAPEUTICS, 2024, 46 (08) : 612 - 621
  • [39] Correction to: Niraparib: A Review in First-Line Maintenance Therapy in Advanced Ovarian Cancer
    Arnold Lee
    Targeted Oncology, 2022, 17 : 89 - 89
  • [40] Niraparib exposure-response relationship in patients (pts) with newly diagnosed advanced ovarian cancer (AOC).
    Monk, Bradley J.
    Romero, Ignacio
    Graybill, Whitney
    Churruca, Cristina
    O'Malley, David M.
    Lund, Bente
    Yap, Oi Wah S.
    Baurain, Jean-Francois
    Rose, Peter Graham
    Denys, Hannelore
    Ghamande, Sharad A.
    Pisano, Carmela
    Fabbro, Michel
    Braicu, Elena Ioana
    Calvert, Paula
    Amit, Amnon
    Prendergast, Emily
    Milton, Ashley
    Zhang, Zhi-Yi
    Martin, Antonio Gonzalez
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345